THE DEVELOPMENT OF DRUG TOLERANCE DURING LONG-TERM BETA₂-AGONIST BRONCHODILATOR THERAPYCHERVINSKY P.1978; CHEST; USA; DA. 1978; VOL. 73; NO 6 SUPPL.; PP. 1001-1002Article

SIXTY DAY TRIAL OF A NEW INHALANT DOSAGE FORM OF METAPROTERENOL.CHERVINSKY P.1977; ANN. ALLERGY; U.S.A.; DA. 1977; VOL. 38; NO 2; PP. 107-111; BIBL. 14 REF.Article

EFFECT OF ORAL METAPROTERENOL AT HALF-STRENGTH IN ASTHMATIC ADULTS: A DOUBLE-BLIND COMPARISON WITH EPHEDRINECHERVINSKY P.1978; CURR. THERAPEUT. RES.; USA; DA. 1978; VOL. 23; NO 5; PP. 575-583; BIBL. 15 REF.Article

DOUBLE-BLIND STUDY OF IPRATROPIUM BROMIDE, A NEW ANTICHOLINERGIC BRONCHODILATOR.CHERVINSKY P.1977; J. ALLERGY CLIN. IMMUNOL.; U.S.A.; DA. 1977; VOL. 59; NO 1; PP. 22-30; BIBL. 10 REF.Article

CLINICAL EVALUATION OF FENOTEROL AEROSOL IN ASTHMA.CHERVINSKY P.1977; ANN. ALLERGY; U.S.A.; DA. 1977; VOL. 39; NO 3; PP. 179-183; BIBL. 4 REF.Article

CASE REPORT: EXACERBATION OF ASTHMA BY TIMOLOLNOYES JH; CHERVINSKY P.1980; ANN. ALLERGY; ISSN 0003-4738; USA; DA. 1980; VOL. 45; NO 5; PP. 301; BIBL. 3 REF.Article

INCIDENCE OF ORAL CANDIDIASIS DURING THERAPY TRIAMCINOLONE ACETONIDE AEROSOLCHERVINSKY P; PETRACO AJ.1979; ANN. ALLERGY; USA; DA. 1979; VOL. 43; NO 2; PP. 80-83; BIBL. 18 REF.Article

METAPROTERENOL TABLETS: THEIR DURATION OF EFFECT BY COMPARISON WITH EPHEDRINECHERVINSKY P; CHERVINSKY G.1975; CURR. THERAPEUT. RES.; U.S.A.; DA. 1975; VOL. 17; NO 6; PP. 507-518; BIBL. 11REF.Article

EFFICACY AND SAFETY OF TRIAMCINOLONE ACETONIDE AEROSOL IN CHRONIC ASTHMA. RESULTS OF A MULTICENTER, SHORT-TERM CONTROLLED AND LONG-TERM OPEN STUDYBERNSTEIN IL; CHERVINSKY P; FALLIES CJ et al.1982; CHEST; ISSN 0012-3692; USA; DA. 1982; VOL. 81; NO 1; PP. 20-26; BIBL. 14 REF.Article

IgG subtype abnormalities with normal total IgG in a clinical allergy practiceNOYES, J; WOODMANSEE, D; CHERVINSKY, P et al.Annals of allergy. 1986, Vol 57, Num 4, pp 273-275, issn 0003-4738Article

Clinical review of once-daily beclomethasone dipropionate for seasonal allergic rhinitis. CommentaryCHERVINSKY, P; KROSNICK, A.Clinical therapeutics. 1996, Vol 18, Num 5, pp 789-796, issn 0149-2918Conference Paper

Duration of action of a single dose of azelastine in patients with chronic asthmaCHERVINSKY, P; GROSSMAN, J; FREITAG, J. J et al.The Journal of asthma. 1995, Vol 32, Num 2, pp 141-145, issn 0277-0903Article

Ipratropium bromide nasal spray 0.03% and beclomethasone nasal spray alone and in combination for the treatment of rhinorrhea in perennial rhinitisDOCKHORN, R; AARONSON, D; PEARLMAN, D et al.Annals of allergy, asthma, & immunology. 1999, Vol 82, Num 4, pp 349-359, issn 1081-1206Article

Double-strength beclomethasone dipropionate (84 μg/spray) aqueous nasal spray in the treatment of seasonal allergic rhinitisPRENNER, B. M; CHERVINSKY, P; LORBER, R. R et al.Journal of allergy and clinical immunology. 1996, Vol 98, Num 2, pp 302-308, issn 0091-6749Article

Effectiveness of azelastine nasal solution in seasonal allergic rhinitisSTORMS, W. W; PEARLMAN, D. S; CHERVINSKY, P et al.Ear, nose & throat journal. 1994, Vol 73, Num 6, pp 382-394, issn 0145-5613, 9 p.Article

Multicenter, double-blind, placebo-controlled trial of triamcinolone acetonide nasal aerosol in the treatment of perennial allergic rhinitisSPECTOR, S; BRONSKY, E; GORDER, J. W et al.Annals of allergy. 1990, Vol 64, Num 3, pp 300-305, issn 0003-4738Article

Multicenter study of bitolterol and isoproterenol nebulizer solutions in nonsteroid-using patientsPINNAS, J. L; BERNSTEIN, I. L; NEIDL, M. J et al.Journal of allergy and clinical immunology. 1987, Vol 79, Num 5, pp 768-775, issn 0091-6749Article

Fluticasone propionate powder and lack of clinically significant effects on hypothalamic-pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthmaLI, J. T. C; FORD, L. B; CHERVINSKY, P et al.Journal of allergy and clinical immunology. 1999, Vol 103, Num 6, pp 1062-1068, issn 0091-6749Article

Inhaled salmeterol and fluticasone : a study comparing monotherapy and combination therapy in asthmaPEARLMAN, D. S; STRICKER, W; WEINSTEIN, S et al.Annals of allergy, asthma, & immunology. 1999, Vol 82, Num 3, pp 257-265, issn 1081-1206Article

Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthmaNOONAN, M. J; CHERVINSKY, P; BRANDON, M et al.The European respiratory journal. 1998, Vol 11, Num 6, pp 1232-1239, issn 0903-1936Article

Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthmaCONDEMI, J. J; CHERVINSKY, P; GOLDSTEIN, M. F et al.Journal of allergy and clinical immunology. 1997, Vol 100, Num 4, pp 467-474, issn 0091-6749Article

Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD₄) receptor antagonist, in patients with chronic asthmaREISS, T. F; ALTMAN, L. C; CHERVINSKY, P et al.Journal of allergy and clinical immunology. 1996, Vol 98, Num 3, pp 528-534, issn 0091-6749Article

Duration of action of oral albuterol in an asthmatic populationROSEN, J. P; CHERVINSKY, P; TROCHELMANN, L et al.Annals of allergy. 1986, Vol 56, Num 1, pp 28-33, issn 0003-4738Article

Hydrofluoroalkane-134a beclomethasone dipropionate, 400 μg, is as effective as chlorofluorocarbon beclomethasone dipropionate, 800 μg, for the treatment of moderate asthmaGROSS, G; THOMPSON, P. J; CHERVINSKY, P et al.Chest. 1999, Vol 115, Num 2, pp 343-351, issn 0012-3692Article

The effectiveness of once-daily dosing of inhaled flunisolide in maintaining asthma controlZUWALLACK, R. L; ROSEN, J. P; LOTNER, G. Z et al.Journal of allergy and clinical immunology. 1997, Vol 99, Num 3, pp 278-285, issn 0091-6749Article